Top compounds associated with response to PRDM6


Feature Type Standardized
Nominal ANOVA
mRNA ML334 diastereomer CTRPv2 pan-cancer AAC 0.063 0.2
mRNA embelin GDSC1000 pan-cancer AAC 0.048 0.2
mRNA TL-2-105 GDSC1000 pan-cancer AAC -0.044 0.2
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.2
mRNA Pyrimethamine GDSC1000 pan-cancer AAC -0.072 0.2
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.048 0.2
mRNA MLN2238 CTRPv2 pan-cancer AAC -0.047 0.2
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.046 0.2
mRNA AS601245 GDSC1000 pan-cancer AAC 0.046 0.2
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.063 0.2
Download CSV